News

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, ...

Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences

Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in ...

BioInvent International: Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001 at ESMO 2025

Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ("BioInven ...
PMLive21h

Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by ...
The Manila Times1d

Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep” or 'the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for ...
The Manila Times2d

Immutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep” or 'the Company”), a late-stage immunotherapy company targeting cancer ...
Morningstar29d

MAIA Biotechnology to Present Two Posters Featuring ... - Morningstar

MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a ...
The Pharma Letter16d

Recordati Rare Diseases touts new data in Cushing’s syndrome

Italian pharma major Recordati presented four poster presentations and one product theater featuring the company’s endocrinology portfolio at the Endocrine Society’s annual meeting, ENDO 2025, taking ...

National conference on modern medical research inaugurated at AIMSR in Chittoor

National conference titled Connectomics-2025, focusing on the convergence of Omics, Bioinformatics, and Data Science for modern medical research, inaugurated ...

ProMIS Neurosciences Inc.: ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer's Association ...

Presentation to highlight the Company's proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 Posters highlighting PRECISE-AD, the Company's Phase 1b clinical trial design and ...
Oncology Nurse Advisor1d

Bosutinib Shows Promise in Treating Children With Newly Diagnosed Ph+ CML

Researchers sought to determine whether bosutinib would be safe and effective in treating pediatric patients with Ph+ CML.
International Atomic Energy Agency7d

IAEA and FAO Showcase Nuclear Solutions at Global Biotech Conference

The Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture showcased the impact of nuclear techniques on agricultural innovation at the FAO Global Agrifood Biotechnologies Conference, ...